The influence of PD-L1 expression levels on the efficacy of combination therapy in thymic epithelial tumors.

Han SiXiaoshuang FuYue HaoYina WangGen LinDong WangChunwei XuYongchang ZhangZhengbo Song

Published in: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico (2024)

PD-L1 expression affects the PFS of patients. High expression of PD-L1 patients with TETs responded better to combination therapy, which could provide a therapeutic option in clinic. Besides, other targeted treatments should be considered.

Keyphrases

combination therapy
end stage renal disease
chronic kidney disease
newly diagnosed
ejection fraction
poor prognosis
primary care
prognostic factors
peritoneal dialysis
cancer therapy
patient reported outcomes
long non coding rna